Type(s) of Cancer
Desmoid Fibromatosis
Desmoid Fibromatosis
Study Phase
Phase 3
Study Completion Date
July 2019
July 2019
NCT02066181Uploaded 04-14-2021
Access via NCI by Request
PDS UID: nci-data-465
A Phase III, Double Blind, Randomized, Placebo-Controlled Trial of Sorafenib in Desmoid Tumors or Aggressive Fibromatosis (DT/DF)
Files: NCT02066181-D1



Data DictionaryNCT02066181-D1-Data-Dictionary_0.pdf

DATANCT02066181-D1-Dataset_0.csv

OTHERREADME.pdf
Files: NCT02066181-D2



Data DictionaryNCT02066181-D2-Data-Dictionary_0.pdf

DATANCT02066181-D2-Dataset_0.csv

OTHERREADME.pdf
Files: NCT02066181-D3



Data DictionaryNCT02066181-D3-Data-Dictionary_0.pdf

DATANCT02066181-D3-Dataset_0.csv

OTHERREADME.pdf
Files: NCT02066181-D4



Data DictionaryNCT02066181-D4-Data-Dictionary_0.pdf

DATANCT02066181-D4-Dataset_0.csv

OTHERREADME.pdf
Files: NCT02066181-D5



Data DictionaryNCT02066181-D5-Data-Dictionary_0.pdf

DATANCT02066181-D5-Dataset_0.csv

OTHERREADME.pdf
Files: NCT02066181-D6



Data DictionaryNCT02066181-D6-Data-Dictionary_0.pdf

DATANCT02066181-D6-Dataset_0.csv

OTHERREADME.pdf